New Jersey Man Dies From Aggressive Lung Cancer, Linked to Vaping

A man from New Jersey has tragically passed away due to an aggressive form of lung cancer, which doctors believe may be linked to his use of e-cigarettes. This case is considered to be the first of its kind.

The 51-year-old, who has not been publicly identified, had been vaping for over ten years after quitting traditional cigarettes in 2009.

He sought medical assistance in 2020 after experiencing chest pain, shortness of breath, unusual weight loss, and coughing up blood.

During examinations, physicians identified a tumor in his left lung, roughly the size of a pack of cards. This type of cancer is typically associated with heavy tobacco consumption.

However, a chest scan just two years prior showed no signs of complications, prompting his medical team to suspect that vaping might have contributed to his condition.

The tumor had spread to tissue around his heart, making surgery an impossible option.

He started chemotherapy, but the cancer advanced quickly, leading to his death just three months after his diagnosis.

His case, featured in the American Journal of Case Reports, is thought to be the first to indicate a possible connection between e-cigarette use and cancer in individuals.

Previous research had only shown such links in laboratory animals.

Doctors from AtlantiCare Regional Medical Center in Atlantic City noted that while a direct cause-and-effect relationship cannot be determined, this case underscores a potential association between e-cigarette use and cancer development.

They emphasized the need for further research into the long-term consequences of vaping and its role in the growth of lung cancer.

While other instances of cancer among vapers have been reported, many of those cases involved older patients with extensive smoking histories, complicating efforts to isolate the effects of vaping alone.

Dr. James Finigan, a pulmonologist who specializes in lung cancer treatment, mentioned that studies indicate the risk of cancer is substantially higher—up to four times more—for those who both vape and smoke compared to those who solely smoke cigarettes.

Interestingly, the New Jersey patient had stopped smoking traditional cigarettes over a decade ago and experienced rapid clinical decline following chemotherapy.

The medical team pointed out that although firm conclusions are elusive, the patient’s young age, minimal history of combustible tobacco use, fast tumor proliferation, lack of chemotherapy response, and swift deterioration could suggest a distinct or more aggressive cancer pattern.

They’ve called for more investigation into the impacts of extended e-cigarette usage.

E-cigarettes produce an aerosol by heating liquids that often contain nicotine, flavorings, and various harmful chemicals. Inhaling this vapor can introduce detrimental substances deep into the lungs, including formaldehyde and other compounds known to contribute to cancer.

Upon detection, the tumor had taken up around two-thirds of his left lung.

Tests confirmed he had squamous cell carcinoma (SCC), which accounts for a sizable portion of lung cancer cases in the U.S.

Each year, around 226,000 new lung cancer cases emerge, predominantly in men and long-term smokers.

SCC can be particularly deceptive, often presenting no obvious symptoms early on, leading signs to be misinterpreted as common conditions like allergies or bronchitis.

When detected early, SCC has a five-year survival rate of about 50 percent. If it spreads beyond the lungs, however, this rate plummets to approximately seven percent.

Initially, the patient was sent home after diagnosis, with plans for outpatient treatment. But within two weeks, he returned to the hospital with severe pain. The tumor had enlarged enough to compress his airways, making breathing difficult.

Doctors inserted a stent to alleviate pressure in his lungs and initiated radiation and chemotherapy treatments. Unfortunately, the cancer continued to spread, leading to his death within two months.

The authors of the report are urging more research into the cancer risks associated with e-cigarette use, especially as long-term users reach ages when cancer typically develops.

They also advocate for modified cancer screening protocols to include chronic vapers, particularly those with over a decade of usage.

They noted that early detection could have led to timely treatment and potentially better outcomes.

Dr. Finigan stressed the importance of identifying lung cancer early, whether through screening or managing incidental lung nodules, as it is the most effective way to reduce lung cancer mortality.

Currently, around 16 million American adults, which is roughly 6.5 percent of the population, are e-cigarette users. The highest usage rates are among young adults between 18 and 24, with over 15 percent of that demographic reporting regular use.

Among minors, about 1.6 million middle and high school students still vape, although this figure has seen declines since its peak in 2019.